NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Clinical Laserthermia Systems AB (publ) (ST: CLS-B)

 
CLS-B Technical Analysis
3
As on 2nd Sep 2025 CLS-B STOCK Price closed @ 10.08 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.58 & Buy for SHORT-TERM with Stoploss of 7.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CLS-BSTOCK Price

Open 11.20 Change Price %
High 11.82 1 Day -0.56 -5.26
Low 9.70 1 Week 3.28 48.24
Close 10.08 1 Month 5.13 103.64
Volume 596262 1 Year 10.00 12500.00
52 Week High 23.44 | 52 Week Low 0.08
 
ST Sweden Most Active Stocks
ENERS 0.00 %
FING-B 0.01 0.00%
IMMNOV 0.73 -6.41%
LIPI 0.22 -4.35%
WYLD 0.01 0.00%
QUIA 0.00 %
LUNE 21.97 6.65%
POLY 0.04 0.00%
XBRANE 0.28 0.00%
SBB-B 4.64 -4.33%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
FLUI 19.60 104.17%
SPIFF 0.04 33.33%
ECC-B 0.58 18.37%
FRAG 12.85 14.22%
FEEL 0.09 12.50%
ZORDIX-B 6.00 11.52%
DIST 0.43 10.26%
PHLOG-B 0.11 10.00%
APTR 0.11 10.00%
 
ST Sweden Top Losers Stocks
SECI 0.01 -50.00%
SECI 0.01 -50.00%
ZICC 0.25 -34.21%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
GIAB 0.10 -23.08%
 
 
CLS-B
Daily Charts
CLS-B
Intraday Charts
Whats New @
Bazaartrend
CLS-B
Free Analysis
 
CLS-B Important Levels Intraday
RESISTANCE14.17
RESISTANCE12.86
RESISTANCE12.05
RESISTANCE11.24
SUPPORT8.92
SUPPORT8.11
SUPPORT7.30
SUPPORT5.99
 
CLS-B Forecast September 2025
4th UP Forecast53.8
3rd UP Forecast39.78
2nd UP Forecast31.11
1st UP Forecast22.45
1st DOWN Forecast-2.29
2nd DOWN Forecast-10.95
3rd DOWN Forecast-19.62
4th DOWN Forecast-33.64
 
CLS-B Weekly Forecast
4th UP Forecast10.12
3rd UP Forecast10.11
2nd UP Forecast10.10
1st UP Forecast10.09
1st DOWN Forecast10.07
2nd DOWN Forecast10.06
3rd DOWN Forecast10.05
4th DOWN Forecast10.04
 
CLS-B Forecast2025
4th UP Forecast56.94
3rd UP Forecast41.91
2nd UP Forecast32.62
1st UP Forecast23.33
1st DOWN Forecast-3.17
2nd DOWN Forecast-12.46
3rd DOWN Forecast-21.75
4th DOWN Forecast-36.78
 
 
CLS-B Other Details
Segment EQ
Market Capital 305537600.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
CLS-B Address
CLS-B
 
CLS-B Latest News
 
Your Comments and Response on Clinical Laserthermia Systems AB (publ)
 
CLS-B Business Profile
Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service